Recent News

• 09.25.2025 - Biotech on Tap
• 09.25.2025 - Biotech on Tap
• 09.15.2025 - Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
• 09.15.2025 - Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
• 09.15.2025 - Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
• 09.02.2025 - Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
• 09.02.2025 - Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025

Recent Filings

• 09.05.2025 - 8-K Current report
• 08.11.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.11.2025 - 8-K Current report
• 08.11.2025 - EX-99.1 EX-99.1